{"disease":{"id":"lobular-breast-carcinoma-in-situ","name":"lobular breast carcinoma in situ"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06133465","title":"Pure Florid and Pleomorphic Lobular Carcinoma in Situ of the Breast: Towards an Increasingly Uniform Management","phase":"","overall_status":"COMPLETED","enrollment_count":1063,"lead_sponsor_name":"Istituto Oncologico Veneto IRCCS","has_results":false},{"nct_id":"NCT05178498","title":"Impact of Dietary Inflammatory Potential on Breast Cancer Risk","phase":"","overall_status":"RECRUITING","enrollment_count":960,"lead_sponsor_name":"Ohio State University Comprehensive Cancer Center","has_results":false},{"nct_id":"NCT05410951","title":"LobularCard Trial: Searching for Novel Germline Mutations in Lobular Breast Cancer Patients","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":800,"lead_sponsor_name":"European Institute of Oncology","has_results":false},{"nct_id":"NCT04496739","title":"Making Informed Choices on Incorporating Chemoprevention Into Care (MiCHOICE)","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":412,"lead_sponsor_name":"SWOG Cancer Research Network","has_results":false},{"nct_id":"NCT06184750","title":"Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT02961790","title":"Oxybutynin Chloride in Managing Hot Flashes","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"Academic and Community Cancer Research United","has_results":true},{"nct_id":"NCT02515110","title":"Hypofractionated Regional Nodal Irradiation Clinical Trial for Women With Breast Cancer","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":137,"lead_sponsor_name":"Virginia Commonwealth University","has_results":false},{"nct_id":"NCT01219075","title":"Soy Isoflavones Supplementation in Treating Women at High Risk For or With Breast Cancer","phase":"NA","overall_status":"COMPLETED","enrollment_count":110,"lead_sponsor_name":"University of Southern California","has_results":false},{"nct_id":"NCT05755269","title":"Adding a Genetic Risk Evaluation to Standard Breast Cancer Risk Assessment for African American and Hispanic Women","phase":"","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT03323658","title":"Bexarotene in Preventing Breast Cancer in Patients at High Risk for Breast Cancer","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT01706432","title":"Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":4,"lead_sponsor_name":"University of Chicago","has_results":false}],"total":11},"guidelines":[],"source":"Drug Landscape verified database"}